Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AWX vs DXR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AWX Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–6 Matrix Metrics)

AWX Overall Winner 6-Pillar Tally: AWX 3 – 2 DXR (1 Tie) Matrix Metrics: AWX 4 – 6 DXR

As of Nov 16, 2026, Avalon Holdings Corp. (AWX) is the stronger overall head-to-head candidate over Daxor Corporation (DXR) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). AWX carries a Unified Composite Score of 37.7/100 (SELL) at $2.83 (36.2x Forward P/E, 6.5% operating margin), whereas DXR carries 52.2/100 (HOLD) at $8.36 (64.5x Forward P/E, -5894.3% operating margin).

  • Composite vs. Pillar Nuance: While DXR currently prints a higher short-term Unified Composite Score (52.2/100 HOLD vs. AWX 37.7/100 SELL), AWX captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (6.5% vs. -5894.3% operating margin) and revenue trajectory (+3.2% vs. +25.5% YoY).
  • Technical & Structure Timing Caution: AWX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 63.4); meanwhile DXR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AWX vs DXR
AWX NYSE American Head-to-Head Winner
Avalon Holdings Corp.
Refuse Systems
$2.83
+0.53% 1D
Market Cap $11.0M
TTM Revenue $143M
Forward P/E 36.2x
Beta / 30D Vol 0.35β · 46% Vol
Unified Composite Score
37.7 / 100 SELL
Tech 5.0 Fund 35.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 63
RSI-14: 63.4 · SMA20: $2.64 · SMA50: $2.59
DXR NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap $49.5M
TTM Revenue $31,360
Forward P/E 64.5x
Beta / 30D Vol 0.28β · 32% Vol
Unified Composite Score
52.2 / 100 HOLD
Tech 52.0 Fund 59.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 31
RSI-14: 31.2 · SMA20: $8.91 · SMA50: $10.07

6-Pillar Scorecard Institutional Category Breakdown (AWX 3 – 2 DXR)

Columns: Metric · AWX · DXR
1. Valuation Multiples AWX
Forward P/E 36.2x 64.5x
Trailing P/E 5.5x 7.7x
PEG Ratio 4.39x N/M
EV / Revenue 0.1x N/M
2. Growth & Scale DXR
Revenue Growth (YoY) +3.2% +25.5%
Earnings Growth (YoY) +222.6% +329.3%
TTM Revenue (USD) $143M $31,360
Market Cap $11.0M $49.5M
3. Profitability & Quality DXR
Gross Margin 20.5% 100.0%
Operating Margin 6.5% -5894.3%
Net Profit Margin 1.4% 19861.4%
Return on Equity (ROE) 2.5% 14.2%
4. Balance Sheet & Cash Flow AWX
Cash Generation (TTM) $5.6M N/A
Cash Flow Margin 3.9% N/A
Net Cash / Leverage $9.84 Book/Sh · 2.5% ROE $8.88 Book/Sh · 14.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat AWX
OpEx & R&D Intensity 14.0% of Rev ($20M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Waste Management Operator Medical Instruments & Supplies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AWX (4) vs DXR (6)
Institutional Metric AWX DXR Criterion Row Edge
Market Capitalization
Scale
$11.0M $49.5M Larger Scale DXR
Trailing P/E Ratio
Valuation
5.5x 7.7x Lower Multiple AWX
Forward P/E Ratio
Valuation
36.2x 64.5x Lower Multiple AWX
Revenue Growth (YoY)
Growth
+3.2% +25.5% Higher Growth DXR
Operating Margin (TTM)
Profitability
6.5% -5894.3% Higher Margin AWX
Net Profit Margin
Profitability
1.4% 19861.4% Higher Margin DXR
Return on Equity (ROE)
Capital Efficiency
2.5% 14.2% Higher ROE DXR
52-Week Range Position
Momentum
71% ($2–$3) 2% ($8–$15) Stronger Trend AWX
Beta / 30D Volatility
Risk Regime
0.35β · 46% Vol 0.28β · 32% Vol Lower Realized Risk DXR
Unified Institutional Score
Composite Signal
37.7 / 100 (SELL) 52.2 / 100 (HOLD) Higher Composite DXR
Trailing 12M Revenue (USD)
Operating Scale
$143M $31,360 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
20.5% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
4.39x PEG · 0.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$5.6M ($9.84 Book/Sh · 2.5% ROE) N/A ($8.88 Book/Sh · 14.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AWX +30.07 pp
AWX: +13.2% · DXR: -16.87%
3M Horizon AWX +20.73 pp
AWX: +1.07% · DXR: -19.66%
6M Horizon AWX +30.64 pp
AWX: +13.2% · DXR: -17.44%
1Y Horizon AWX +33.27 pp
AWX: +0.0% · DXR: -33.27%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AWX vs DXR. Trailing 12-month operating profitability (AWX 6.5% vs DXR -5894.3%) and valuation multiples (AWX 36.2x vs DXR 64.5x Forward P/E) are benchmarked directly in Pillar 4 below.

AWX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$143M
Gross Margin20.5%
Op. Margin6.5%
ROE / Fwd P/E2.5% · 36.2x
DXR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$31,360
Gross Margin100.0%
Op. Margin-5894.3%
ROE / Fwd P/E14.2% · 64.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AWX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AWX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DXR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DXR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AWX Moat Profile Cyclical / Execution-Driven Positioning
Waste Management Operator
Competes within the Waste Management value chain with $11.0M market capitalization and 6.5% operating margin.
OpEx & R&D Reinvestment 14.0% of Rev ($20M)
90D Engineering Disclosures 0 Published
DXR Moat Profile Cyclical / Execution-Driven Positioning
Medical Instruments & Supplies Operator
Competes within the Medical Instruments & Supplies value chain with $49.5M market capitalization and -5894.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AWX vs DXR Key Questions & Quantitative Answers

As of Nov 16, 2026, Avalon Holdings Corp. (AWX) is the stronger overall head-to-head candidate over Daxor Corporation (DXR) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). AWX carries a Unified Composite Score of 37.7/100 (SELL) at $2.83 (36.2x Forward P/E, 6.5% operating margin), whereas DXR carries 52.2/100 (HOLD) at $8.36 (64.5x Forward P/E, -5894.3% operating margin). Composite vs. Pillar Nuance: While DXR currently prints a higher short-term Unified Composite Score (52.2/100 HOLD vs. AWX 37.7/100 SELL), AWX captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (6.5% vs. -5894.3% operating margin) and revenue trajectory (+3.2% vs. +25.5% YoY). Technical & Structure Timing Caution: AWX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 63.4); meanwhile DXR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DXR leads the Growth & Scale pillar: AWX posts +3.2% YoY revenue growth and +222.6% YoY earnings growth on $143M TTM revenue (20.5% gross margin, 6.5% operating margin), compared with DXR at +25.5% YoY revenue growth and +329.3% YoY earnings growth on $31,360 TTM revenue (100.0% gross margin, -5894.3% operating margin). On trailing 12-month operating scale, AWX generates $143M in USD-normalized revenue versus $31,360 for DXR. In operating R&D and SG&A reinvestment, AWX deploys 14.0% of Rev ($20M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DXR.

AWX screens cheaper on headline valuation multiples. AWX trades at 36.2x Forward P/E, 5.5x Trailing P/E, 4.39x PEG, and 0.1x EV/Revenue (3.9% FCF margin), whereas DXR trades at 64.5x Forward P/E, 7.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AWX (2.5% ROE) versus DXR (14.2% ROE) capital efficiency.

In options market volatility and institutional positioning, AWX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.35β · 46% Vol realized risk). By comparison, DXR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 32% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.